Senokot 7.5mg tablets Adult

Krajina: Spojené kráľovstvo

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktívna zložka:

Senna fruit

Dostupné z:

Reckitt Benckiser Healthcare (UK) Ltd

ATC kód:

A06AB06

INN (Medzinárodný Name):

Senna fruit

Dávkovanie:

7.5mg

Forma lieku:

Oral tablet

Spôsob podávania:

Oral

Trieda:

No Controlled Drug Status

Typ predpisu:

Valid as a prescribable product

Prehľad produktov:

BNF: 01060200; GTIN: 5011417579169

Príbalový leták

CUSTOMER INFO:
Minimum Point Size =
9.00pt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BARCODE INFO
Barcode Type:
Barcode Number:
Magnification:
Truncated By:
Full Height:
Bar Height (Smallest Bar):
BWR:
Encoded Data:
Trident Reference No:
ZEN Ref:
Action:
Brand:
Category:
Segment Group:
Segment:
Pack Size:
Market/Country:
Date:
Component Code
(2D if applicable)
:
2
nd
Component Code
(if applicable)
:
Parent Technical Packaging Specification:
Finished Goods Code:
Supply Point:
3rd Party Code
Pharmacode No/NE:
Edgemark Position:
CAD Cam Ref:
Printer:
Substrate:
001010(73)
N/A
RB Hull
N/A
3139701
Senokot
Stimulant Laxative
Senna
Regular Tablet
20 x 12Pack
RB482518
Please note that any low resolution paper Canon colour copies
associated with this job should be referred to for content, layout
and colour separation only.
STUDIO USE ONLY
v2.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
Cutter 2 (if applicable)
Guides 2 (if applicable)
Westrock MPS (Tewkesbury, UK)
Skt-Lft-D8372157-160mmx250mm
TR2244001
Paper White
UK
03/09/21
C
Karthikeyan Shanmuganathan
3209075
N/A
G=2; O=0; R=0; - KS - 03/09/21 11:17:21
RB Artwork and
Print Specification
D8372157
Artwork Type:
BW Commercial
10
mm
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
1
LTH
PANTONE 347 C
Colours (Leaflet)
RBH Contact:
Alexander Titmus
Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T: [phone]
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
3209075
3209075
PACKAGE LEAFLET: INFORMATION FOR THE USER
SENOKOT 7.5 MG TABLETS ADULT
SENNA FRUIT (PODS)
READ THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or advice.
•
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist have
told you.
•
If any of the side effects get serious or if you notice any side

Súhrn charakteristických

OBJECT 1
SENOKOT 7.5 MG TABLETS ADULT
Summary of Product Characteristics Updated 28-Apr-2020 | Reckitt
Benckiser Healthcare (UK) Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Senokot 7.5 mg Tablets Adult
2. Qualitative and quantitative composition
Each tablet contains powdered Alexandrian Senna fruit (pods) (_Cassia
senna _L. (_C. acutifolia _Delile))
and Tinnevelly Senna fruit (pods) (_Cassia angustifolia _Vahl)
equivalent to 7.5mg hydroxyanthracene
glycosides, calculated as sennoside B.
Each tablet also contains 15.82 mg lactose monohydrate
For full list of excipients, see section 6.1
3. Pharmaceutical form
Tablets
4. Clinical particulars
4.1 Therapeutic indications
For the short-term relief of occasional constipation.
4.2 Posology and method of administration
For oral administration.
The correct individual dose is the smallest required to produce a
comfortable soft-formed motion.
Adults and the elderly: Swallow one to two tablets at night
Should not be used in c